27^th Global Nephrology, Urology and Kidney Failure Congress

Renal Precision Medicine & Genomic Risk Profiling

Renal precision medicine is transforming the understanding and management of kidney diseases by integrating genomics, multi-omics, and computational modeling to identify individual risk patterns and therapeutic responses. Genomic risk profiling allows clinicians to detect hereditary predispositions, rare variants, and molecular signatures linked to glomerular, tubular, and metabolic kidney disorders long before clinical symptoms emerge. By combining whole-exome sequencing, biomarker analytics, transcriptomics, and pharmacogenomics, physicians can develop individualized treatment strategies that optimize drug efficacy and reduce nephrotoxic burden. Precision phenotyping enhances the ability to categorize patients based on molecular pathways rather than broad disease classifications, leading to targeted interventions for complex conditions such as APOL1-associated kidney disease, polycystic kidney disorders, and immune-mediated nephropathies. AI-driven algorithms and predictive models further support real-time risk stratification, enabling early identification of high-risk individuals and guiding therapeutic escalation. As precision medicine expands, it facilitates improved patient outcomes, minimized progression to end-stage renal disease, and reduced healthcare burden through proactive, personalized renal care.